(19)
(11) EP 4 580 641 A2

(12)

(88) Date of publication A3:
18.04.2024

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23861278.2

(22) Date of filing: 31.08.2023
(51) International Patent Classification (IPC): 
A61K 35/17(2025.01)
A61P 31/00(2006.01)
A61P 37/00(2006.01)
C12N 5/10(2006.01)
C12N 15/113(2010.01)
C12N 9/22(2006.01)
A61K 35/15(2025.01)
A61P 35/00(2006.01)
C12N 15/11(2006.01)
A61K 48/00(2006.01)
C12N 15/63(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61P 31/00; A61P 37/00; C12N 2510/00; C12N 2501/515; C12N 5/0646; C07K 14/4738; A61K 40/15; A61K 40/4258; A61K 40/11; A61K 40/31
(86) International application number:
PCT/US2023/031654
(87) International publication number:
WO 2024/049971 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2022 US 202263374447 P

(71) Applicant: Baylor College of Medicine
Houston, TX 77030 (US)

(72) Inventors:
  • METELITSA, Leonid, S.
    Houston, TX 77030 (US)
  • HECZEY, Andras
    Houston, TX 77030 (US)
  • XU, Xin
    Houston, TX 77030 (US)
  • COURTNEY, Amy, N.
    Houston, TX 77030 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) MODULATION OF B-CELL TRANSLOCATION GENE 1 (BTG1) FOR USE IN ADOPTIVE CELL THERAPY